Lung Transplantation in Hungary From Cardiac Surgeons' Perspective.


Journal

Transplantation proceedings
ISSN: 1873-2623
Titre abrégé: Transplant Proc
Pays: United States
ID NLM: 0243532

Informations de publication

Date de publication:
May 2019
Historique:
entrez: 19 5 2019
pubmed: 19 5 2019
medline: 27 6 2019
Statut: ppublish

Résumé

Thoracic organ transplantation made a fresh start in Hungary with the first double lung transplant in December 2015. This major leap in Hungarian transplantation was preceded by almost 10 years of preparation, new infrastructure development, and structural changes not only at the organizational level but in human resources as well. In the following years, until recently, altogether 47 lung transplants were performed on 24 men and 23 women. The underlying pathologies were as follows: chronic obstructive pulmonary disease, 25; cystic fibrosis, 11; idiopathic pulmonary fibrosis, 7; as well as other diseases, including bronchiectasis, eosinophilic granuloma, lymphangioleiomyomatosis, and primary pulmonary hypertension in 4 cases. The youngest recipient was 13 and the oldest was 65 years old. Overall survival rates at 30 days and at 1 year were 96% and 82%, respectively. No patients were lost in the cystic fibrosis and other diseases group, whereas the 1-year survival rates of the chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis groups were 73% and 71%, respectively. The results show the robustness and viability of the program, although there is still opportunity for further improvement. In this short paper, we summarize the fields of possible further cooperation of thoracic and cardiac teams as well as future challenges facing the new Hungarian lung transplant program.

Identifiants

pubmed: 31101211
pii: S0041-1345(19)30605-0
doi: 10.1016/j.transproceed.2019.04.007
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1263-1267

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

L Fazekas (L)

Department of Cardiac Surgery, Semmelweis University, Budapest, Hungary; Department of Thoracic Surgery, Semmelweis University, Budapest, Hungary. Electronic address: fazekas.levente@med.semmelweis-univ.hu.

Á Ghimessy (Á)

Department of Thoracic Surgery, Semmelweis University, Budapest, Hungary; Department of Thoracic Surgery, National Institute of Oncology, Budapest, Hungary.

B Gieszer (B)

Department of Thoracic Surgery, Semmelweis University, Budapest, Hungary; Department of Thoracic Surgery, National Institute of Oncology, Budapest, Hungary.

P Radeczky (P)

Department of Thoracic Surgery, Semmelweis University, Budapest, Hungary; Department of Thoracic Surgery, National Institute of Oncology, Budapest, Hungary.

L Mészáros (L)

Department of Thoracic Surgery, Semmelweis University, Budapest, Hungary; Department of Thoracic Surgery, National Institute of Oncology, Budapest, Hungary.

K Török (K)

Department of Thoracic Surgery, Semmelweis University, Budapest, Hungary; Department of Thoracic Surgery, National Institute of Oncology, Budapest, Hungary.

L Bogyó (L)

Department of Thoracic Surgery, Semmelweis University, Budapest, Hungary; Department of Thoracic Surgery, National Institute of Oncology, Budapest, Hungary.

I Hartyánszky (I)

Department of Cardiac Surgery, Semmelweis University, Budapest, Hungary.

M Pólos (M)

Department of Cardiac Surgery, Semmelweis University, Budapest, Hungary.

L Daróczi (L)

Department of Cardiac Surgery, Semmelweis University, Budapest, Hungary.

L Agócs (L)

Department of Thoracic Surgery, Semmelweis University, Budapest, Hungary; Department of Thoracic Surgery, National Institute of Oncology, Budapest, Hungary.

Á Kocsis (Á)

Department of Thoracic Surgery, Semmelweis University, Budapest, Hungary; Department of Thoracic Surgery, National Institute of Oncology, Budapest, Hungary.

T Bartók (T)

Department of Anaesthesiology and Intensive Care, National Institute of Oncology, Budapest, Hungary.

T Dancs (T)

Department of Anaesthesiology and Intensive Care, National Institute of Oncology, Budapest, Hungary.

K Kormosói Tóth (KK)

Department of Anaesthesiology and Intensive Care, National Institute of Oncology, Budapest, Hungary.

N Schönauer (N)

Department of Anaesthesiology and Intensive Care, National Institute of Oncology, Budapest, Hungary.

I Madurka (I)

Department of Anaesthesiology and Intensive Care, National Institute of Oncology, Budapest, Hungary.

J Elek (J)

Department of Anaesthesiology and Intensive Care, National Institute of Oncology, Budapest, Hungary.

B Döme (B)

Department of Thoracic Surgery, Semmelweis University, Budapest, Hungary.

F Rényi-Vámos (F)

Department of Thoracic Surgery, Semmelweis University, Budapest, Hungary; Department of Thoracic Surgery, National Institute of Oncology, Budapest, Hungary.

G Lang (G)

Department of Thoracic Surgery, Semmelweis University, Budapest, Hungary; Department of Thoracic Surgery, National Institute of Oncology, Budapest, Hungary.

A Farkas (A)

Department of Thoracic Surgery, Semmelweis University, Budapest, Hungary; Department of Thoracic Surgery, National Institute of Oncology, Budapest, Hungary.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH